Table 3 Clinical characteristics of the patients with a high iron score and treatment-related death AML indicates acute myeloid leukemia
From: The transplant iron score as a predictor of stem cell transplant survival
Demographics | Disease | Donor | Conditioning | Iron Score (pRBCs) | Survival | Cause of Death |
|---|---|---|---|---|---|---|
53 y/o male | ALL (CR2) | MRD | Cytoxan/TBI | 2 (45) | 16 days | Clostridial sepsis |
24 y/o female | AML (CR1) | MUD | Busulfan/Cytoxan | 2 (42) | 26 days | Septic shock (culture negative) |
48 y/o female | AML (CR2) | MRD | Cytoxan/TBI | 3 (38) | 8 days | Pneumonia/ARDS |
62 y/o female | Refractory AML | MRD | Non-ablative | 2 (43) | 50 days | CMV pneumonia |
50 y/o female | MDS | MUD | Cytoxan/TBI | 3 (35) | 6 days | Pneumonia/ARDS |
32 y/o male | AML (CR1) | MRD | Cytoxan/TBI | 2 (58) | 13 days | Septic shock (culture negative) |
49 y/o female | Aplastic anemia | MUD | Cytoxan/TBI | 2 (30) | 27 days | Gram-negative sepsis |